Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against ‘John Doe’ ‘Naked’ Short-Sellers of Lunai Common Stock

Law firms Dickinson Wright and Fox Rothschild filed a federal lawsuit on behalf of Lunai Bioworks alleging securities fraud and market manipulation by unnamed naked short sellers. The complaint details systematic failures to deliver shares reaching 234.6 times the maximum baseline rate, with trading volumes exceeding Lunai's total outstanding shares by multiples. The lawsuit seeks compensatory damages and injunctive relief to halt the manipulative trading.

05/12/2026, 12:12 AM • GlobeNewswire

Stock Market Today: Nasdaq, S&P 500 Futures Gain While Dow Slips Amid Israel-Lebanon Ceasefire Extension—Intel, SAP, Lunai Bioworks In Focus (UPDATED)

U.S. stock futures were mixed on Friday following Thursday's decline as President Trump extended the Israel-Lebanon ceasefire by three weeks. The Dow Jones fell 0.20%, S&P 500 declined 0.028%, while Nasdaq rose 0.56%. Key stocks in focus include Intel (beat earnings expectations), SAP (beat earnings), Lunai Bioworks (announced $20M transaction), Procter & Gamble (earnings expected), and FreeCast (signed DIRECTV distribution deal). Oil prices rose to $97.15/barrel, and the Fed is expected to hold rates unchanged in April.

04/24/2026, 8:48 AM • Benzinga

Stock Market Today: Dow Jones, S&P 500 Futures Edge Lower Amid Extension Of Israel-Lebanon Ceasefire—Intel, SAP, Lunai Bioworks In Focus

U.S. stock futures were mixed on Friday following Thursday's decline as President Trump extended the Israel-Lebanon ceasefire by three weeks. The Dow Jones fell 0.20% while the Nasdaq rose 0.56%. Key stocks in focus include Intel (beat earnings expectations), SAP (beat earnings), Lunai Bioworks (announced $20M transaction), Procter & Gamble (earnings expected), and FreeCast (signed DIRECTV distribution deal). Oil prices rose to $97.15/barrel, and the Fed is expected to hold rates unchanged in April.

04/24/2026, 5:31 AM • Benzinga

Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

Lunai Bioworks announced that its subsidiary BioSymetrics has secured its first revenue-generating defense collaboration to develop an AI-enabled platform for chemical threat assessment. The multi-year commercial engagement combines zebrafish-based phenotypic screening with AI-driven mechanism-of-action prediction to detect and characterize chemical threats, with additional engagements under discussion.

04/07/2026, 9:05 AM • Benzinga

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Law firm Kahn Swick & Foti is investigating the proposed merger between Predictive Oncology and Renovaro, questioning whether the transaction adequately values the company.

08/19/2025, 9:44 PM • GlobeNewswire

AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

The White House is encouraging AI adoption in healthcare through regulatory sandboxes, with several tech and biotech companies advancing AI-powered healthcare solutions focused on diagnostics, drug development, and workflow optimization.

07/29/2025, 3:01 PM • Benzinga